Ubs Group Ag Mirum Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 184,589 shares of MIRM stock, worth $8.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,589

Previous 124,390 48.4%

Holding current value

$8.68 Million

Previous $4.85 Million 57.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$37.85 - $46.65 $2.28 Million - $2.81 Million	60,199 Added 48.4%	184,589 $7.63 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $2.48 Million - $3.29 Million	73,647 Added 145.14%	124,390 $4.85 Million
Q2 2024 Aug 13, 2024	SELL	$23.57 - $34.85 $2.5 Million - $3.7 Million	-106,168 Reduced 67.66%	50,743 $1.73 Million
Q1 2024 May 13, 2024	BUY	$24.92 - $30.02 $956,180 - $1.15 Million	38,370 Added 32.37%	156,911 $3.94 Million
Q4 2023 Feb 09, 2024	BUY	$27.14 - $34.93 $3.21 Million - $4.13 Million	118,348 Added 61320.21%	118,541 $3.5 Million
Q3 2023 Nov 09, 2023	SELL	$24.63 - $32.85 $2.72 Million - $3.63 Million	-110,453 Reduced 99.83%	193 $6,000
Q2 2023 Aug 11, 2023	BUY	$23.51 - $30.09 $1.65 Million - $2.11 Million	70,080 Added 172.76%	110,646 $2.86 Million
Q1 2023 May 12, 2023	SELL	$19.19 - $24.1 $1.28 Million - $1.6 Million	-66,550 Reduced 62.13%	40,566 $974,000
Q4 2022 Feb 08, 2023	BUY	$17.59 - $23.83 $1.57 Million - $2.12 Million	89,139 Added 495.85%	107,116 $2.09 Million
Q3 2022 Nov 10, 2022	BUY	$19.98 - $29.44 $359,180 - $529,242	17,977 New	17,977 $378,000
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $38,455 - $59,370	-2,481 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $22,537 - $33,417	1,727 Added 229.05%	2,481 $39,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $10,518 - $15,215	754 New	754 $15,000
Q2 2021 Aug 13, 2021	SELL	$15.84 - $20.6 $18,390 - $23,916	-1,161 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$16.29 - $21.92 $218,171 - $293,574	-13,393 Reduced 92.02%	1,161 $23,000
Q4 2020 Feb 11, 2021	BUY	$15.75 - $25.45 $3,228 - $5,217	205 Added 1.43%	14,554 $254,000
Q3 2020 Nov 12, 2020	SELL	$18.4 - $26.59 $26,643 - $38,502	-1,448 Reduced 9.17%	14,349 $277,000
Q2 2020 Jul 31, 2020	SELL	$11.51 - $20.97 $13,846 - $25,226	-1,203 Reduced 7.08%	15,797 $307,000
Q1 2020 May 01, 2020	BUY	$9.38 - $23.79 $114,276 - $289,833	12,183 Added 252.92%	17,000 $238,000
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $8,406 - $31,831	1,229 Added 34.25%	4,817 $118,000
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $32,866 - $52,994	3,588 New	3,588 $36,000

Others Institutions Holding MIRM

# of Institutions

211

Shares Held

53.8M

Call Options Held

2.6K

Put Options Held

99.7K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.73B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account